Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Roche has teamed with venture capital firm Versant Ventures and the drug discovery incubator Inception Sciences to launch Inception 5, a biotech firm devoted to finding multiple sclerosis drugs. Inception 5 will use a screening platform developed at the University of California, San Francisco, to find small molecules that repair damaged myelin, the insulating layer around nerves. Versant will provide equity financing; Roche will provide milestone-based funding in exchange for the right to acquire Inception 5 down the road. This is the second build-to-buy company formed by the three partners. In 2012, they created Inception 3 to develop hearing loss treatments.
This article has been sent to the following recipient: